On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

Opioid agonist treatment could substantially reduce drug related deaths if used more widely
New evidence that opioid agonists such as methadone and buprenorphine could substantially reduce drug related deaths if more widely used in the community and prison, and for longer, has been published in Lancet Psychiatry.
Association between county jail incarceration and cause-specific county mortality in the USA, 1987–2017: a retrospective, longitudinal study
Mass incarceration has collateral consequences for community health, which are reflected in county-level health indicators, including county mortality rates. County jail incarceration rates are associated with all-cause mortality rates in the USA. We assessed the causes of death that drive the relationship between county-level jail incarceration and mortality.
Accelerated Overdose Deaths Linked With COVID-19
More than 81 000 people died of drug overdoses in the US between June 2019 and May 2020, a record-breaking number that CDC officials suggested is related to the coronavirus disease 2019 (COVID-19) pandemic.
Harm reduction in Europe: a framework for civil society-led monitoring
Civil society organisations (CSOs) play a vital role in developing and implementing effective measures to reduce the harms of drug use. They are also fundamental actors to monitor and evaluate programmes and policies for improvement. While harm reduction services are subject to monitoring, and international and European indicators exist, a framework for civil society-led monitoring does not exist. This paper analyses the challenges and added values of developing such a framework for the European region.
Association of Medical Stimulants With Mortality in the US From 2010 to 2017
The role of nonopioids in the drug overdose epidemic in the US is frequently overshadowed. From 2015 to 2016, mortality rates involving cocaine and psychostimulants were smaller than opioids, but were rising faster than opioids.1 We examined individual substances listed on death certificates to better understand stimulant-associated mortality and assess rates over time.
Association between county level cannabis dispensary counts and opioid related mortality rates in the United States
Higher medical and recreational storefront dispensary counts are associated with reduced opioid related death rates, particularly deaths associated with synthetic opioids such as fentanyl. This study highlights the importance of considering the complex supply side of related drug markets and how this shapes opioid use and misuse.
This report covers drug trends, explores the drivers behind drug related deaths and gives insight into the impact of the global pandemic and lockdown restrictions.
Methamphetamine overdose deaths rise sharply in USA
Methamphetamine overdose deaths surged in an eight-year period in the United States, according to a study published today. The analysis revealed rapid rises across all racial and ethnic groups, but American Indians and Alaska Natives had the highest death rates overall. The research was conducted at the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
Shooting Up: infections among people who inject drugs in the UK, 2019
Drug use in the United Kingdom (UK) is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. Through this report, we explore infections, associated risks and behaviours among PWID in the UK to the end of 2019, as well as presenting preliminary data on the impact of COVID-19 on PWID and services in 2020.
Share this on: